Überblick von RCT
Research Corporation Technologies (RCT) specializes in early-stage funding for biotechnology companies and technologies originating at universities and research institutions. Through investments, partnerships, and licensing programs, the venture capital and management firm helps to develop therapeutics, medical devices, and medical technology. A UK affiliate, Cambridge Research Bioventures, and an alliance with Start-Up Australia pursue biotechnology opportunities in those countries. RCT also invests in new materials, optics technologies, and geophysics instruments. Founded in 1987, the company has more than $300 million in assets under management.
